These compounds may interact with:
Peptidyl-prolyl cis-trans isomerase FKBP1A
Potentially involved in: fibrodysplasia ossificans progressiva; malignant hyperthermia; reticulate acropigmentation of kitamura; left ventricular noncompaction; legionnaires' disease; bipolar disorder; liver cirrhosis, experimental; squamous cell carcinoma of esophagus; astrocytic glioma; cystic fibrosis; glioblastoma; group 3 medulloblastoma; malignant mesothelioma; osteosarcoma; pediatric high grade glioma; pick disease; psoriasis; tuberculosis; esophageal squamous cell carcinoma; angiomyolipoma of kidney
Disease data sourced from Pharos.